Edition:
United States

Guangdong Zhongsheng Pharmaceutical Co Ltd (002317.SZ)

002317.SZ on Shenzhen Stock Exchange

11.54CNY
1:56am EDT
Change (% chg)

¥-0.03 (-0.26%)
Prev Close
¥11.57
Open
¥11.57
Day's High
¥11.66
Day's Low
¥11.46
Volume
1,692,934
Avg. Vol
4,175,954
52-wk High
¥14.10
52-wk Low
¥10.32

Latest Key Developments (Source: Significant Developments)

Guangdong Zhongsheng Pharmaceutical receives GMP certificate
Thursday, 18 May 2017 04:39am EDT 

May 18(Reuters) - Guangdong Zhongsheng Pharmaceutical Co Ltd <002317.SZ> ::* Says it received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration.* Says certificate issued to hard capsules, granules, pills, tablets manufactured by the company and the valid period is until May 15, 2022.  Full Article

Guangdong Zhongsheng Pharmaceutical sees H1 2017 net profit up 10-20 pct
Tuesday, 25 Apr 2017 04:07am EDT 

April 25 (Reuters) - Guangdong Zhongsheng Pharmaceutical Co Ltd <002317.SZ>: :* Sees net profit for H1 2017 to increase by 10 percent to 20 percent, or to be 245.3 million yuan to 267.6 million yuan, compared to net profit of the same period in 2016 (223.0 million yuan).* Comments that increased sales is the main reason for the forecast.  Full Article

Guangdong Zhongsheng Pharma to pay annual cash div as 1.80 yuan per 10 shares for FY 2016
Tuesday, 25 Apr 2017 01:14am EDT 

April 25(Reuters) - Guangdong Zhongsheng Pharmaceutical Co Ltd <002317.SZ> : :* Says it plans to pay annual cash dividend as 1.80 yuan(pre-tax) per 10 shares as FY 2016 div payment.  Full Article

Guangdong Zhongsheng Pharma sees Q1 net profit up 15-20 pct y/y
Thursday, 23 Mar 2017 04:00am EDT 

Guangdong Zhongsheng Pharmaceutical Co Ltd <002317.SZ> :Says it sees Q1 net profit to rise 15-20 percent y/y to 106.6-111.3 million yuan($15.48-16.16 million).  Full Article

Guangdong Zhongsheng Pharmaceutical receives patent license
Tuesday, 14 Mar 2017 12:25am EDT 

Guangdong Zhongsheng Pharmaceutical Co Ltd <002317.SZ> : Says it received a patent license (No. ZL201310432986.5), for manufacturing method of ivabradine and its hydrochloride .Patent valid for 20 years.  Full Article

Guangdong Zhongsheng Pharma posts 39.6 pct y/y rise in prelim 2016 profit
Tuesday, 21 Feb 2017 06:55am EST 

Guangdong Zhongsheng Pharmaceutical Co Ltd <002317.SZ> :Says preliminary 2016 net profit up 39.6 percent y/y at 414.3 million yuan ($60.20 million).  Full Article

Guangdong Zhongsheng Pharmaceutical and unit receives patents for package design
Wednesday, 24 Aug 2016 10:36pm EDT 

Guangdong Zhongsheng Pharmaceutical Co Ltd <002317.SZ>: : Says the co and its unit received patents for package design of its four pharmaceutical products .Says patents valid for ten years since April 20.  Full Article

Guangdong Zhongsheng Pharmaceutical receives patent license
Sunday, 14 Aug 2016 11:21pm EDT 

Guangdong Zhongsheng Pharmaceutical Co., Ltd. <002317.SZ>: Says it receives a patent license (No. ZL201410364489.0), for medicine for ischemic stroke .Says patent valid for 20 years since July 29, 2014.  Full Article

Guangdong zhongsheng Pharmaceutical sets up medical technology JV in Guangzhou
Monday, 4 Jul 2016 02:00am EDT 

Guangdong zhongsheng Pharmaceutical Co Ltd <002317.SZ>: Says it invested 4.4 million yuan to set up JV with an individual in Guangzhou on June 17 . Says the JV is engaged in medical technology .Says the company is holding 44 percent stake in the JV.  Full Article

Guangdong Zhongsheng Pharmaceutical receives invention patent
Wednesday, 29 Jun 2016 09:03pm EDT 

Guangdong Zhongsheng Pharmaceutical Co Ltd <002317.SZ>: Says it received patent of invention, for a preparation method of treating ocular inflammation .Says patent valid for 20 years since June 8.  Full Article

More From Around the Web